Transdermal permeability of triamcinolone acetonide lipid nanoparticles

References

• SandySUKennethAAJeffreySDKeloids and hypertrophic scars: review and treatment strategiesSemin Cutan Med Surg1992182159171
   Google Scholar
• RabelloFBSouzaCDFarina JúniorJAUpdate on hypertrophic scar treatmentClinics (Sao Paulo)201469856557325141117
   PubMed Web of Science ®Google Scholar
• LedonJASavasJFrancaKChaconANouriKIntralesional treatment for keloids and hypertrophic scars: a reviewDermatol Surg201339121745175710.1111/dsu.1234624299571
   PubMed Web of Science ®Google Scholar
• BrissettAESherrisDAScar contractures, hypertrophic scars, and keloidsFacial Plast Surg200117426327210.1055/s-2001-1882711735059
   PubMedGoogle Scholar
• SadeghiniaASadeghiniaSComparison of the efficacy of intralesional triamcinolone acetonide and 5-fluorouracil tattooing for the treatment of keloidsDermatol Surg201238110410910.1111/j.1524-4725.2011.02137.x22093096
   PubMed Web of Science ®Google Scholar
• MorganSMSherrySCCombination treatment of CO2 fractional laser, pulsed dye laser, and triamcinolone acetonide injection for refractory keloid scars on the upper backJ Cosmet Laser Ther201315316617010.3109/14764172.2013.78044823452175
   PubMedGoogle Scholar
• GerdGGHansCKTatianaPHypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategiesMol Med2011171–211312510.2119/molmed.2009.0015320927486
   PubMedGoogle Scholar
• FinkenMJJMulDCushing’s syndrome and adrenal insufficiency after intradermal triamcinolone acetonide for keloid scarsEur J Pediatr201016991147114910.1007/s00431-010-1185-820186428
   PubMedGoogle Scholar
• SandySUArndtKADoverJSKeloids and hypertrophic scars: review and treatment strategiesSemin Cutan Med Surg1999218159171
   Google Scholar
• XiCLihuaPJianqingGNovel topical drug delivery systems and their potential use in scars treatmentAsian J Pharm Sci201273155167
   Google Scholar
• MofikoyaBOAdeyemoWLAbdus-salamAAKeloid and hyper-trophic scars: a review of recent developments in pathogenesis and managementNig Q J Hosp Med200717413413918320758
   PubMedGoogle Scholar
• MeseciEKayatasSApiMBozaACikmanMSComparison of the effectiveness of topical silicone gel and corticosteroid cream on the pfannenstiel scar prevention – a randomized controlled trialGinekol Pol2017881159159810.5603/GP.a2017.010729303212
   PubMedGoogle Scholar
• TapeinosCBattagliniMCiofaniGAdvances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseasesJ Control Release201726430633210.1016/j.jconrel.2017.08.03328844756
   PubMed Web of Science ®Google Scholar
• ZhangYTHanMQShenLNZhaoJHFengNPSolid lipid nanoparticles formulated for transdermal aconitine administration and evaluated in vitro and in vivoJ Biomed Nanotechnol201511235136126349311
   PubMed Web of Science ®Google Scholar
• CharoenputtakhunPOpanasopitPRojanarataTNgawhirunpatTAll-trans retinoic acid-loaded lipid nanoparticles as a transdermal drug delivery carrierPharm Dev Technol201419216417210.3109/10837450.2013.76326123356887
   PubMed Web of Science ®Google Scholar
• SinglaSKSachdevaVCurrent and emerging lipid-based systems for transdermal drug deliveryTher Deliv2015691063107010.4155/tde.15.6626390067
   PubMedGoogle Scholar
• GaurPKMishraSPurohitSSolid lipid nanoparticles of guggul lipid as drug carrier for transdermal drug deliveryBiomed Res Int2013201375069024058913
   PubMed Web of Science ®Google Scholar
• PardeikeJHommossAMüllerRHLipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal productsInt J Pharm20093661–217018410.1016/j.ijpharm.2008.10.00318992314
   PubMed Web of Science ®Google Scholar
• Al-RasheedNMAl-RasheedNMAbdel BakyNAProphylactic role of α-lipoic acid and vitamin E against zinc oxide nanoparticles induced metabolic and immune disorders in rat’s liverEur Rev Med Pharmacol Sci201418121813182824992626
   PubMedGoogle Scholar
• PappKMenterMARamanMA randomized phase 2b trial of baricitinib an oral JAKl/JAK2 inhibitor, in patients with moderate-to-severe psoriasisBr J Dermatol201617461266127610.1111/bjd.1440326800231
   PubMed Web of Science ®Google Scholar
• PunwaniNBurnTScherlePDownmodulation of key inflammatory cell markers with a topical Janus kinase 1/2 inhibitorBr J Dermatol2015173498999710.1111/bjd.1399426123031
   PubMed Web of Science ®Google Scholar
• ChenJWeiNLopez-GarciaMDevelopment and evaluation of resveratrol, Vitamin E, and epigallocatechin gallate loaded lipid nanoparticles for skin care applicationsEur J Pharm Biopharm201711728629110.1016/j.ejpb.2017.04.00828411056
   PubMed Web of Science ®Google Scholar
• MoralesJOValdésKMoralesJOyarzun-AmpueroFLipid nanoparticles for the topical delivery of retinoids and derivativesNanomedicine (Lond)201510225326910.2217/nnm.14.15925600970
   PubMed Web of Science ®Google Scholar
• BanJZhangYHuangXCorneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasoneInt J Nanomedicine2017121329133910.2147/IJN.S12619928243093
   PubMed Web of Science ®Google Scholar
• MorrisDEWuLZhaoLLAcute and Chronic animal models for excessive dermal scarring: quantitative studyPlast Reconstr Surg19961003674682
   Google Scholar
• GongYFZhangXMYuJEffect of recombinant human endostatin on hypertrophic scar fibroblast apoptosis in a rabbit ear modelBiomed Pharmacother20179168068610.1016/j.biopha.2017.04.11628499239
   PubMed Web of Science ®Google Scholar
• WangQDongYGengSSuHGeWZhenCPhotodynamic therapy inhibits the formation of hypertrophic scars in rabbit ears by regulating metalloproteinases and tissue inhibitor of metalloproteinase-1Clin Exp Dermatol201439219620110.1111/ced.1226524475901
   PubMedGoogle Scholar
• ParhiRSureshPPreparation and characterization of solid lipid nanoparticles-a reviewCurr Drug Discov Technol20129121622235925
   PubMedGoogle Scholar
• KatheNHenriksenBChauhanHPhysicochemical characterization techniques for solid lipid nanoparticles: principles and limitationsDrug Dev Ind Pharm201440121565157510.3109/03639045.2014.90984024766553
   PubMed Web of Science ®Google Scholar
• NandiniPTDoijadRCShivakumarHNDandagiPMFormulation and evaluation of gemcitabine-loaded solid lipid nanoparticlesDrug Deliv201522564765110.3109/10717544.2013.86050224283392
   PubMed Web of Science ®Google Scholar
• LütfiGMüzeyyenDPreparation and characterization of polymeric and lipid nanoparticles of pilocarpine HCl for ocular applicationPharm Dev Technol201318370170910.3109/10837450.2012.70529822813238
   PubMedGoogle Scholar